The Food and Drug Administration (FDA) revealed the barrier-breaking change to its rules Tuesday (Jan. 3). The revision enables FDA-certified pharmacies for the first time to carry and dispense mifepristone, the first drug in a two-step process commonly referred to as medical or chemical abortion. Women also will continue to be able to receive the pills by mail.
Leaders of the Southern Baptist Ethics & Religious Liberty Commission (ERLC) and 40 other pro-life organizations sent a letter Tuesday that called on members of Congress to seek a “robust pro-life agenda” through the passage of new laws and the protection of spending measures that must be approved each year.
The FDA’s decision to expand the distribution of mifepristone is the latest in a series of actions taken by President Biden and his administration in an effort to minimize the effect of the Supreme Court’s reversal of the 1973 Roe v. Wade ruling. In June 2022, the high court returned abortion policy to the states by overturning Roe, which legalized abortion throughout the country.
Pro-life advocates objected to the FDA change.
- Walgreens becomes first major pharmacy to say it plans to sell abortion pills as Walmart, CVS, and others consider hurdles and threats of backlash | Christian News Network
- Biden DOJ renders 'outrageous' political opinion on mailing abortion drugs (liveaction.org)
- EXPLAINER: The FDA expands abortion pill access in local pharmacies | Baptist Press
- CVS and Walgreens plan to carry abortion pill, become ‘centers of death,’ pro-life advocates say (pregnancyhelpnews.com)